Toggle light / dark theme

Fluid eMTBR-tau243 as a Biomarker of Mixed 3-Repeat and 4-Repeat Tau Pathology

This cohort study evaluates the biofluid eMTBR-tau243 across a range of mixed 3-repeat and 4-repeat tauopathies, including Alzheimer disease, chronic traumatic encephalopathy, and frontotemporal lobar degeneration with MAPT.

Leave a Comment

Lifeboat Foundation respects your privacy! Your email address will not be published.